Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia

Abstract

Our results demonstrate that doripenem has similar efficacy as meropenem in HAP or VAP patients. With an aim to enhance antibiotic diversity, doripenem could be an alternative choice for patients with HAP or VAP, except for those with hematological malignancies.